Bridging Thrombolysis Versus Direct Mechanical Thrombectomy in Acute Ischemic Stroke

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 410 participants.

Also called NCT03192332

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 410 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03192332
Other papers using this trial's data
  • MRI vs CT for Baseline Imaging Evaluation in Acute Large Artery Ischemic Stroke: A Subanalysis of the SWIFT-DIRECT Trial Neurology, 2024-01-23 DOI, PubMed 38165324, PMC12337051 PubMed links an erratum for this paper. Erratum: PMID 38830175 In the PMC Open Access subset under CC BY.
  • SWIFT DIRECT: Solitaire™ With the Intention For Thrombectomy Plus Intravenous t-PA Versus DIRECT Solitaire™ Stent-retriever Thrombectomy in Acute Anterior Circulation Stroke: Methodology of a randomized, controlled, multicentre study International journal of stroke : official journal of the International Stroke Society, 2022-07 DOI, PubMed 34569878
  • Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial Lancet (London, England), 2022-07-09 DOI, PubMed 35810756

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Austria, Canada, Finland, France, Germany, Spain, Switzerland, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03192332. Randomized; single masking; primary purpose treatment. Start 2017-11-29 (actual); primary completion 2021-05-14 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Bridging Thrombolysis Versus Direct Mechanical Thrombectomy in Acute Ischemic Stroke
Acronym
SWIFT DIRECT
Intervention (Device)
Stent-retriever thrombectomy with revascularization device of the Solitaire™ type
Intervention (Drug)
Intravenous thrombolysis with recombinant tissue-type plasminogen activator (IV t-PA)
Lead sponsor
Insel Gruppe AG, University Hospital Bern (class: other)
Collaborator
Medtronic (class: industry)

Record details

Record id
cardio:ct-nct03192332
Content hash
797b245d502aa5e1891d0ca25e446f9e0713ce98c3e7dc5d94fb1d071ad2a591